Stoughton, MA, United States of America

Eleonora Presman

This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2010.


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eleonora Presman: Innovator in LINGO-1 Polypeptide Research

Introduction

Eleonora Presman is a notable inventor based in Stoughton, MA (US). She has made significant contributions to the field of biochemistry, particularly in the study of LINGO-1 polypeptides. Her innovative work has led to the development of a patent that addresses important aspects of protein interactions.

Latest Patents

Eleonora Presman holds a patent titled "Method for identifying or designing a candidate agent that interacts with LINGO-1 polypeptide using a LINGO-1 three-dimensional structure." This patent relates to LINGO-1 polypeptides, LINGO-1 polypeptide/ligand complexes, crystals of LINGO-1 polypeptides, crystals of LINGO-1 polypeptide/ligand complexes, and associated methods and software systems. She has 1 patent to her name, showcasing her expertise in this specialized area.

Career Highlights

Presman is currently employed at Wyeth, a well-known pharmaceutical company. Her role involves extensive research and development in the field of biochemistry, where she applies her knowledge to create innovative solutions.

Collaborations

Throughout her career, Eleonora has collaborated with esteemed colleagues such as William Stuart Somers and Brian Dwyer. These partnerships have further enhanced her research and contributed to the advancement of her projects.

Conclusion

Eleonora Presman is a pioneering inventor whose work in LINGO-1 polypeptides has the potential to impact various applications in biochemistry and pharmaceuticals. Her contributions reflect her dedication to innovation and research in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…